urea has been researched along with trimethoprim, sulfamethoxazole drug combination in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gregory, J; Lester, E | 1 |
Marinella, MA | 1 |
Avellaneda, AA; Fraser, TN; Graviss, EA; Musher, DM | 1 |
Argyres, DP; Kesner, JM; Mercier, RC; Vilay, AM; Walker, SE; Wong, CS; Yardman-Frank, JM | 1 |
El-Temsahy, MM; El-Zawawy, LA; Gaafar, MR; Hassan, AY; Shalaby, TI | 1 |
5 other study(ies) available for urea and trimethoprim, sulfamethoxazole drug combination
Article | Year |
---|---|
Drug interference with reagent strip method for measuring urea.
Topics: Aged; Bacterial Infections; Drug Combinations; Female; Humans; Indicators and Reagents; Methods; Reagent Strips; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urea | 1982 |
Case report: reversible hyperkalemia associated with trimethoprim- sulfamethoxazole.
Topics: Aged; Electrolytes; Humans; Hyperkalemia; Male; Potassium; Soft Tissue Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Urea | 1995 |
Acute kidney injury associated with trimethoprim/sulfamethoxazole.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Creatinine; Dialysis; Female; Humans; Incidence; Male; Metabolic Clearance Rate; Middle Aged; Trimethoprim, Sulfamethoxazole Drug Combination; Urea | 2012 |
Trimethoprim and sulfamethoxazole transmembrane clearance during modeled continuous renal replacement therapy.
Topics: Anti-Bacterial Agents; Blood Proteins; Chromatography, High Pressure Liquid; Dialysis Solutions; Hemodiafiltration; Hemofiltration; Hemoglobins; Humans; In Vitro Techniques; Membranes, Artificial; Metabolic Clearance Rate; Models, Chemical; Osmolar Concentration; Permeability; Renal Dialysis; Serum Albumin; Trimethoprim, Sulfamethoxazole Drug Combination; Urea | 2014 |
Silver nanoparticles as a therapeutic agent in experimental cyclosporiasis.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Coccidiostats; Creatinine; Cyclophosphamide; Cyclospora; Cyclosporiasis; Diarrhea; Feces; Humans; Immunocompetence; Immunocompromised Host; Immunosuppressive Agents; Interferon-gamma; Liver; Male; Metal Nanoparticles; Mice; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Oocysts; Silver; Trimethoprim, Sulfamethoxazole Drug Combination; Urea | 2019 |